Crossmark

Efficacy and safety of ATRA plus arsenic trioxide versus ATRA plus chemotherapy in newly diagnosed acute promyelocytic leukemia: a grade-assessed systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-026-15932-4

Published Online: 2026-03-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmad, Hassan https://orcid.org/0009-0004-0139-7166
Henna, Fathimathul

Khurram, Sana https://orcid.org/0009-0001-3739-415X
Khan, Ayesha https://orcid.org/0009-0001-3181-1872
Ahmed, Alisha https://orcid.org/0009-0001-2779-7211
Ali, Muhammad Hasnain https://orcid.org/0009-0003-2914-6943
Hassan, Mohammad Aitzaz https://orcid.org/0009-0006-4333-5793
Abbas, Muhammad

Farooq, Danyal

Muhammad, Sher

Basit, Ali Abdul https://orcid.org/0009-0003-1624-208X
Ahmad, Ashfaq https://orcid.org/0009-0005-8043-884X
License Information

Text and Data Mining valid from 2026-03-29

Version of Record valid from 2026-05-12
More Information

Article History

Received: 28 November 2025

Accepted: 24 March 2026

First Online: 29 March 2026

Declarations

:

: Not Applicable.

: Not Applicable.

: The authors declare no competing interests.